Urinary

Review on pharmacognostic, phytochemical and pharmacological characteristics of medicinal plants which can be used to design a novel ayurvedic formulation to treat hypertension in multidimensional approaches 

This review from 2023 evaluates extraction methods of the active phytoconstituents and pharmacognostic, physiochemical, phytochemical and quantitative analysis parameters, and the different pharmacological modes of action for ayurvedic plants traditionally used for the management of blood pressure. Concluding that Boerhavia diffusa consists of active ingredients: Liriodendron & Syringaresinol mono β-D-Glucosidase which can exhibit Ca2+ channel …

Review on pharmacognostic, phytochemical and pharmacological characteristics of medicinal plants which can be used to design a novel ayurvedic formulation to treat hypertension in multidimensional approaches  Read More »

Ethnomedicinal uses, phytochemistry and pharmacological properties of the genus Boerhavia 

This review from 2016 focused on traditional uses, phytochemistry, pharmacology and toxicology of Boerhavia genus to support potential scope for advanced ethnopharmacological study. 180 compounds from Boerhavia genus were isolated, of which B. diffusa alone, shared around 131 compounds and for most of which it is currently an exclusive source.  References: Patil, K. S., & …

Ethnomedicinal uses, phytochemistry and pharmacological properties of the genus Boerhavia  Read More »

Review on pharmacognostic, phytochemical and pharmacological characteristics of medicinal plants which can be used to design a novel ayurvedic formulation to treat hypertension in multidimensional approaches 

This review from 2023 evaluates extraction methods of the active phytoconstituents and pharmacognostic, physiochemical, phytochemical and quantitative analysis parameters, and the different pharmacological modes of action for ayurvedic plants traditionally used for the management of blood pressure. Concluding that Boerhavia diffusa consists of active ingredients: Liriodendron & Syringaresinol mono β-D-Glucosidase which can exhibit Ca2+ channel …

Review on pharmacognostic, phytochemical and pharmacological characteristics of medicinal plants which can be used to design a novel ayurvedic formulation to treat hypertension in multidimensional approaches  Read More »

Ethnomedicinal uses, phytochemistry and pharmacological properties of the genus Boerhavia 

This review from 2016 focused on traditional uses, phytochemistry, pharmacology and toxicology of Boerhavia genus to support potential scope for advanced ethnopharmacological study. 180 compounds from Boerhavia genus were isolated, of which B. diffusa alone, shared around 131 compounds and for most of which it is currently an exclusive source.  References: Patil, K. S., & …

Ethnomedicinal uses, phytochemistry and pharmacological properties of the genus Boerhavia  Read More »

D-mannose powder for prophylaxis of recurrent urinary tract infections in women: A randomized clinical trial 

In 2014 researchers conducted a clinical trial with 308 women with a history of recurrent UTIs. Intervention was prophylactic treatment with either 2 g D-mannose powder, or 50 mg of the antibiotic nitrofurantoin, or in the third group no prophylactic treatment at all. There was a significantly greater rate of recurrent UTI in the group …

D-mannose powder for prophylaxis of recurrent urinary tract infections in women: A randomized clinical trial  Read More »

D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: A systematic review and meta-analysis 

In 2020 a group of researchers investigated the evidence and validity of D-mannose use as an intervention or prophylactic treatment for recurrent urinary tract infections. Eight publications met eligibility. Relative risk of urinary tract infection recurrence comparing D-mannose to placebo was 0.23 (D-mannose n=125, placebo n=123). Concluding that D-mannose is protective for UTI (versus placebo) …

D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: A systematic review and meta-analysis  Read More »

Effectiveness of cranberry capsules to prevent urinary tract infections in vulnerable older persons: A double-blind randomized placebo-controlled trial in long-term care facilities 

In a double-blind, randomized, placebo-controlled trial from 2014, 928 seniors (703 were female) from long-term care facilities were divided into low-risk and high-risk groups for UTIs. Participants were given either 500 mg cranberry extract or placebo twice daily for 12 months. Those defined as “high-risk”, which included participants with long-term catheterization, diabetes or at least …

Effectiveness of cranberry capsules to prevent urinary tract infections in vulnerable older persons: A double-blind randomized placebo-controlled trial in long-term care facilities  Read More »

Cranberry juice capsules and urinary tract infection post-surgery: Results of a randomized trial 

In a randomized trial from 2015, 160 patients undergoing elective gynecologic surgery were randomized to receive 720 mg cranberry fruit extract or placebo twice daily for six weeks post-op. The occurrence of UTI was significantly lower in the cranberry group, 19%, compared to 38% in the placebo group.  References: Foxman B, Cronenwett AEW, Spino C, …

Cranberry juice capsules and urinary tract infection post-surgery: Results of a randomized trial  Read More »

Pollen extract in association with vitamins provides early pain relief in patients affected by chronic prostatitis/chronic pelvic pain syndrome 

In a randomized controlled trial from 2014, patients diagnosed with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) were given 1000 mg flower pollen extract daily or 600 mg ibuprofen three times daily for four weeks. At the end of the treatment period, 75% of patients in the flower pollen extract group had improvements in quality of …

Pollen extract in association with vitamins provides early pain relief in patients affected by chronic prostatitis/chronic pelvic pain syndrome  Read More »

Effects of pollen extract preparation Prostat/Poltit on lower urinary tract symptoms in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome: A randomized, double-blind, placebo-controlled study 

A double blind, placebo-controlled trial from 2006, followed 60 patients with chronic non-bacterial prostatitis/chronic pelvic pain syndrome. They were randomized to treatment with Prostat/Poltit (222 mg flower pollen) or placebo daily for six months. Of the patients who took the pollen extract, 73% had clinical improvements with 20% of participants having complete resolution of symptoms. …

Effects of pollen extract preparation Prostat/Poltit on lower urinary tract symptoms in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome: A randomized, double-blind, placebo-controlled study  Read More »

Scroll to Top